OCT4 staining in testicular tumors: A sensitive and specific marker for seminoma and embryonal carcinoma

American Journal of Surgical Pathology

Volumn 28, Issue 7, 2004, Pages 935-940

  Jones, Timothy D ^a   Ulbright, Thomas M ^a   Eble, John N ^a   Baldridge, Lee Ann ^a   Cheng, Liang ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarker; CD30; Embryonal carcinoma; Germ cell tumors; Neoplasia; Oct3 4; POU5F1; Seminoma; Testis

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; CD30 ANTIGEN; EOSIN; HEMATOXYLIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHORIOCARCINOMA; DIAGNOSTIC TEST; EMBRYONAL CARCINOMA; GERM CELL; GERM CELL TUMOR; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; MAJOR CLINICAL STUDY; MALE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SEMINOMA; SERTOLI CELL TUMOR; SEX CORD TUMOR; STEM CELL; SYNCYTIOTROPHOBLAST; TERATOMA; TESTIS TUMOR; YOLK SAC TUMOR;

ADENOMATOID TUMOR; ANTIGENS, CD30; CARCINOMA, EMBRYONAL; CHORIOCARCINOMA, NON-GESTATIONAL; DNA-BINDING PROTEINS; ENDODERMAL SINUS TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LEYDIG CELL TUMOR; MALE; OCTAMER TRANSCRIPTION FACTOR-3; SEMINOMA; SENSITIVITY AND SPECIFICITY; SERTOLI CELL TUMOR; SEX CORD-GONADAL STROMAL TUMORS; TERATOMA; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 3042719623     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200407000-00014     Document Type: Article

References (44)

1. Albores-Saavedra J, Huffman H, Alvarado-Cabrero I, et al. Anaplastic variant of spermatocytic seminoma. Hum Pathol. 1996;27:650-655.
2. Berney DM, Shamash J, Pieroni K, et al. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology. 2001;39:382-385.
3. Boiani M, Eckardt S, Scholer HR, et al. Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev. 2002;16:1209-1219.
4. Cheng L, Leibovich BC, Bergstralh EJ, et al. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer, 1999;85:2455-2459.
5. Cheng L, Lloyd RV, Weaver AL, et al, The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 2000;6:1896-1899.
6. Cheng L, Nagabhushan M, Pretlow TP, et al. E-cadherin expression in primary and metastatic prostate cancer. Am J Pathol. 1996;148:1375-1380.
7. Cheng L, Pisansky TM, Sebo TJ, et al. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res. 1999;5:2820-2823.
8. Cheng L, Sebo TJ, Cheville JC, et al. P53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer. 1999;85:1293-1299.
9. Cummings OW, Ulbright TM, Eble JN, et al. Spermatocytic seminoma: an immunohistochemical study. Hum Pathol. 1994;25:54-59.
10. Damjanov I. Teratocarcinoma stem cells. Cancer Surv. 1990;9:303-319.
11. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;2:294-298.
12. Grigor KM. A new classification of germ cell tumours of the testis. Eur Urol. 1993;23:93-100.
13. Guillaudeux T, Mattei MG, Depetris D, et al. In situ hybridization localizes the human OTF3 to chromosome 6p21.3→p22 and OTF3L to 12p13. Cytogenet Cell Genet. 1993;63:212-214.
14. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod. 2000;6:999-1004.
15. Hansis C, Tang YX, Grifo JA, et al. Analysis of Oct-4 expression and ploidy in individual human blastomeres. Mol Hum Reprod. 2001;7:155-161.
16. Henley JD, Michael H, Young RH, et al. Solid pattern yolk sac tumor of the testis: a histologic and immunohistochemical study of 9 cases. Lab Invest. 2003;83:153A.
17. Henley JD, Young RH, Ulbright TM. Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma. Am J Surg Pathol. 2002;26:541-550.
18. Hittmair A, Rogatsch H, Hobisch A, et al. CD30 expression in seminoma. Hum Pathol. 1996;27:1166-1171.
19. Jacobsen GK, Rorth M, Osterlind K, et al. Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group. APMIS. 1990;98:377-382.
20. Kraft HJ, Mosselman S, Smits HA, et al. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J Biol Chem. 1996;271:12873-12878.
21. Lamb KA, Rizzino A. Effects of differentiation on the transcriptional regulation of the FGF-4 gene: critical roles played by a distal enhancer. Mol Reprod Dev. 1998;51:218-224.
22. Latza U, Foss HD, Durkop H, et al. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am J Pathol. 1995;146:463-471.
23. Leroy X, Augusto D, Leteurtre E, et al. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem. 2002;50:283-285.
24. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250.
25. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20:8085-8091.
26. Mostofi FK, Spaander P, Grigor K, et al. Consensus on pathological classifications of testicular tumours. Prog Clin Biol Res. 1990;357:267-276.
27. Moul JW, McCarthy WF, Fernandez EB, et al. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res. 1994;54:362-364.
28. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379-391.
29. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372-376.
30. Okamoto K, Okazawa H, Okuda A, et al. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 1990;60:461-472.
31. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
32. Palumbo C, van Roozendaal K, Gillis AJ, et al. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues: implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol. 2002;196:467-477.
33. Pan CX, Kinch MS, Kiener PA, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res. 2004;10:1333-1337.
34. Pera MF, Bennett W, Cerretti DP. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors. Lab Invest. 1997;76:497-504.
35. Pera MF, Bennett W, Cerretti DP. CD30 and its ligand: possible role in regulation of teratoma stem cells. APMIS. 1998;106:169-172.
36. Pesce M, Wang X, Wolgemuth DJ, et al. Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev. 1998;71:89-98.
37. Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 1990;345:686-692.
38. Saijoh Y, Fujii H, Meno C, et al. Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells. 1996;1:239-252.
39. Scholer HR, Dressler GR, Balling R, et al. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 1990;9:2185-2195.
40. Takeda J, Seino S, Bell GI. Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res. 1992;20:4613-4620.
41. Talerman A. Spermatocytic seminoma: clinicopathological study of 22 cases. Cancer. 1980;45:2169-2176.
42. Tomioka M, Nishimoto M, Miyagi S, et al. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 2002;30:3202-3213.
43. Ulbright TM, Amin MB, Young RH. Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum. Washington, DC: Armed Forces Institute of Pathology, 1999.
44. Ulbright TM, Young RH, Scully RE. Trophoblastic tumors of the testis other than classic choriocarcinoma: 'monophasic' choriocarcinoma and placental site trophoblastic tumor: a report of two cases. Am J Surg Pathol. 1997;21:282-288.